Jim has been the founder, inventor, investor, and owner operator in many med-tech / biotech ventures. Having started and operated over 8 different companies since 1990, Jim began working on the Matrix technology, the backbone for InSitu's sustained release drug, AnestaGel, in 2007 and co-founded InSitu Biologics in 2014. Xerox trained out of college, Jim specializes in the total operation for small companies.
For more information:
http://www.insitubiologics.com/
https://www.linkedin.com/in/james-seg...
James Segermark | CEO Money Episode 51 podcasts about history | |
| 1 Likes | 1 Dislikes |
| 14 views views | 360 followers |
| People & Blogs | Upload TimeStreamed live on 1 May 2019 |
Không có nhận xét nào:
Đăng nhận xét